YasminaLauraAbajasMD

PubMed

• Current practices in pediatric hospital-acquired thromboembolism: Survey of the Children's Hospital Acquired Thrombosis (CHAT) Consortium.
  Abrams, C., Jaffray, J., Stillings, A., Branchford, B., Young, G., Goldenberg, N., Abajas, Y., , , Fargo, J., Crary, S., Kumar, R., Woods, G., Narang, S., Cooper, J., ...> ;Research and Practice in Thrombosis and Haemostasis. 2022 Oct 1
• 3 citations
  Quality of life in a large multinational haemophilia B cohort (The B-Natural study) - Unmet needs remain.
  Erik Berntorp, Petra LeBeau, Margaret V Ragni, Munira Borhany, Yasmina L Abajas, Michael D Tarantino, Katharina Holstein, Stacy E Croteau, Raina Liesner, Cristina Tara...> ;Haemophilia. 2022 May 1
• 10 citations
  The B-Natural study—The outcome of immune tolerance induction therapy in patients with severe haemophilia B
  Jan Astermark, Katharina Holstein, Yasmina L. Abajas, Susan Kearney, Stacy E. Croteau, R. Liesner, Eva Funding, Christine L. Kempton, Suchitra S. Acharya, Stefan Letha...> ;Haemophilia. 2021 Jun 12
• Recombinant porcine factor VIII use in bleed treatment in non-severe haemophilia A inhibitor patients: Dosing strategies and efficacy
  Patrick Ellsworth, Sheh-Li Chen, Nigel S. Key, Yasmina L. Abajas, Alice Ma> ;Haemophilia. 2021 Jan 1
• 7 citations
  Natural history study of factor IX deficiency with focus on treatment and complications (B-Natural).
  Amy D. Shapiro, Margaret V. Ragni, Munira Borhany, Yasmina L. Abajas, Michael D. Tarantino, Katharina Holstein, Stacy E. Croteau, R. Liesner, Cristina Tarango, Manuela...> ;Haemophilia. 2021 Jan 1
• 15 citations
  Development of AAV Variants with Human Hepatocyte Tropism and Neutralizing Antibody Escape Capacity.
  Xiaolei Pei, Wenwei Shao, Allene Xing, Charles Askew, Xiaojing Chen, Cai-Bin Cui, Yasmina L. Abajas, David A. Gerber, Elizabeth P. Merricks, Timothy C. Nichols, Wuping...> ;Molecular Therapy. Methods & Clinical Development. 2020 Sep 11
• 4 citations
  Use of plasma-derived factor X concentrate in neonates and infants with congenital factor X deficiency
  Karen L. Zimowski, Catherine E. McGuinn, Yasmina L. Abajas, Corinna L. Schultz, Shipra Kaicker, Glaivy Batsuli> ;Journal of Thrombosis and Haemostasis. 2020 Jul 30
• 12 citations
  Excessive breakthrough bleeding in haemophilia B patients on factor IX-albumin fusion protein prophylactic therapy: A single centre case series
  Brendan Kleiboer, Brenda Nielsen, Alica D Ma, Yasmina L. Abajas, Dougald M. Monroe, Nigel S. Key> ;Haemophilia. 2020 Jan 1
• 14 citations
  Superior human hepatocyte transduction with adeno-associated virus vector serotype 7
  Wenwei Shao, Xiaolei Pei, Cai-Bin Cui, Charles Askew, Amanda Lee Dobbins, Xiaojing Chen, Yasmina L. Abajas, David A. Gerber, R. Jude Samulski, Timothy C. Nichols, Chen...> ;Gene Therapy. 2019 Sep 30
• 27 citations
  An Observational Study from Long-Term AAV Re-administration in Two Hemophilia Dogs
  Junjiang Sun, Wenwei Shao, Xiaojing Chen, Elizabeth P. Merricks, Lauren E. Wimsey, Yasmina L. Abajas, Glenn P. Niemeyer, Clinton D. Lothrop, Paul E. Monahan, R. Jude S...> ;Molecular Therapy. Methods & Clinical Development. 2018 Aug 4
• 2 citations
  DDAVP trial in discrepant non-severe haemophilia A patients.
  Helen Chioma Okoye, Brenda Nielsen, Kristy Lee, Yasmina L. Abajas, Nigel S. Key, Marian A. Rollins-Raval> ;Haemophilia. 2018 May 1
• 8 citations
  A Retrospective Study of the Cytokine Profile Changes in Mice with FVIII Inhibitor Development After Adeno-Associated Virus-Mediated Gene Therapy in a Hemophilia A Mou...
  Junjiang Sun, Zhenhua Yuan, Yasmina L. Abajas, Doreen E. Szollosi, Genlin Hu, Baolai Hua, Xiao Xiao, Chengwen Li> ;Human Gene Therapy. 2017 Oct 26
• 14 citations
  Recombinant porcine factor VIII for high-risk surgery in paediatric congenital haemophilia A with high-titre inhibitor.
  Stacy E. Croteau, Yasmina L. Abajas, Alisa S. Wolberg, Brenda Nielsen, Gerald R. Marx, Christopher W. Baird, Ellis J. Neufeld, Paul E. Monahan> ;Haemophilia. 2017 Mar 1
• Join now to see all

Lectures

• Recombinant Porcine Factor VIII Use in Bleed Treatment in Non-Severe Hemophilia a Inhibitor Patients: Dosing Strategies and Efficacy 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Immune Tolerance Induction for FIX Inhibitors Using Combined B and T Cell Immune Modulation Therapy in Severe Hemophilia B 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018